INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Afton Scientific Capabilities Update January 2026: Fill/Finish
Here, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.
-
Alba® Syringe Platform: Ensuring Stability For Sensitive Drugs
Check out this exciting video showcasing the key advantages of Alba®: innovative coating technology that reduces potential interaction between the drug and container surface.
-
MilliporeSigma Bio-Expo Live February 2025: Upstream Bioprocessing
Review the benefits of implementing a closed and sterile sampling system, such as NovaSeptum®, to improve sampling procedures and meet regulatory expectations.
-
Lyophilization To Enable Drug Products Containing Labile Molecules
Develop lyophilized formulations to overcome stability challenges and significantly extend the shelf life of sensitive therapeutic products.
-
Empowering Innovation: Harnessing CDMO Potential For Sterile Injectables10/20/2025
Specialized CDMOs are essential for meeting the growing demand and complex quality requirements for sterile injectables. Outsourcing provides crucial benefits like cost savings, flexibility, and a strategic focus on core competencies.
-
How Asia and Europe Are Reshaping Biologics Manufacturing4/9/2026
As biologics manufacturing globalizes, companies must balance cost, capacity, risk, and control when choosing between European and Asian supply bases for clinical and commercial success.
-
Cytiva's Aseptic Filling Workcell User Group1/9/2026
Discover how global collaboration among aseptic filling experts is driving innovation and improving operations.
-
Commercially Proven Sterile Fill/Finish With Capacity And Global Backing1/27/2026
Find comprehensive solution with new sterile fill/finish investments supporting complex molecules through robust tech transfer, commercialization expertise, and integrated cGMP manufacturing solutions.
-
Product-Wet Integrity Testing: Risk-Based Strategies5/22/2026
When standard water‑based integrity testing falls short, product‑wet approaches can offer a more representative alternative. Learn how risk‑based strategies are used to establish reliable test limits.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Discover end-to-end containment solutions for bulk handling, isolator technology, and sterile processing that prioritize safety, efficiency, and innovation in hazardous material handling.
-
Oral solid dose manufacturing supports complex formulations with flexible scales, specialized technologies, and integrated packaging for reliable clinical and commercial supply.
-
BD Physioject™ Disposable Autoinjector offers a proven, user-friendly platform for self-injection, enhancing patient comfort, safety, and adherence across multiple chronic disease treatments globally.
-
Used Cytiva Microcell Vial Filler, catalog# 29754759, speeds up to 300 units per load, 1.0 - 50 mL fill range, gloveless robotic isolator, HMI with stainless steel enclosure, serial# PSV00087, built 2023.
-
Accelerate single-cell and low-volume workflows with high precision, fast setup, and surfactant-free dispensing that delivers reproducible results and flexible performance across cell types and reagents.